Literature DB >> 18476203

Clinical significance of Credé's prophylaxis in germany at present.

U B Hoyme1.   

Abstract

The introduction of silver nitrate for prophylaxis of gonococcal ophthalmia neonatorum is one of the milestones of preventive medicine. However, in our time an increasing necessity to review Credé's prophylaxis from both a human rights and a medical standpoint is required. The chairmen of the obstetrics and gynecology departments of the German university hospitals were questioned to learn about their policy and experience. Data were provided by 22 of 28 consulted institutions, representing 31,700 annual deliveries seen over a mean period of 5.5 years. Ocular prophylaxis was in use in 16 (73%) of the reporting hospitals (1% silver nitrate in 14 and gentamicin in 2). A nonspecific conjunctival reaction occurred in 5-10% of the newborns, but no major side effects were seen. Non-gonococcal ophthalmia neonatorum was observed in less than 0.1%; however, institutions without a preventive policy reported up to a 5% incidence of neonatal conjunctivitis, mostly due to Staphylococcus aureus, as well as Neisseria gonorrhoeae in two newborns. Application of silver nitrate is considered a necessary prophylactic measure and safe if it is properly administered. However, major efforts should be directed toward its replacement by alternative antiseptic substances as well as toward chlamydial screening and therapy in pregnancy.

Entities:  

Year:  1993        PMID: 18476203      PMCID: PMC2364679          DOI: 10.1155/S1064744993000080

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  19 in total

Review 1.  Ophthalmia neonatorum due to neisseria gonorrhoeae: prevention and treatment.

Authors:  R Rothenberg
Journal:  Sex Transm Dis       Date:  1979 Apr-Jun       Impact factor: 2.830

2.  Corneal silver deposits following Crede's prophylaxis an examination with electron dispersive x-ray analysis (EDX-analysis) and scanning electron microscope (SEM).

Authors:  G Schirner; N F Schrage; S Salla; C Teping; M Reim; W G Burchard; B Schwab
Journal:  Lens Eye Toxic Res       Date:  1990

3.  Controversies in ocular prophylaxis of newborns.

Authors:  J W Chandler
Journal:  Arch Ophthalmol       Date:  1989-06

4.  1989 Sexually Transmitted Diseases Treatment Guidelines.

Authors: 
Journal:  MMWR Suppl       Date:  1989-09-01

5.  Management of gonococcal ophthalmia neonatorum with single-dose kanamycin and ocular irrigation with saline.

Authors:  A Latif; P Mason; E Marowa; E Paraiwa; F Dhamu; J Tambo; L Gwanzura; D Mapeta; G Jongeling
Journal:  Sex Transm Dis       Date:  1988 Apr-Jun       Impact factor: 2.830

6.  Epidemiology and control of gonococcal ophthalmia neonatorum.

Authors:  M Laga; A Meheus; P Piot
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

7.  Silver nitrate ophthalmic solution and chemical conjunctivities.

Authors:  H Nishida; H M Risemberg
Journal:  Pediatrics       Date:  1975-09       Impact factor: 7.124

8.  Outbreak of erythromycin-resistant staphylococcal conjunctivitis in a newborn nursery.

Authors:  K Hedberg; T L Ristinen; J T Soler; K E White; C W Hedberg; M T Osterholm; K L MacDonald
Journal:  Pediatr Infect Dis J       Date:  1990-04       Impact factor: 2.129

9.  Source of the conjunctival bacterial flora at birth and implications for ophthalmia neonatorum prophylaxis.

Authors:  S J Isenberg; L Apt; R Yoshimori; J W McCarty; S R Alvarez
Journal:  Am J Ophthalmol       Date:  1988-10-15       Impact factor: 5.258

10.  Failure of erythromycin ointment for postnatal ocular prophylaxis of chlamydial conjunctivitis.

Authors:  C Black-Payne; J A Bocchini; C Cedotal
Journal:  Pediatr Infect Dis J       Date:  1989-08       Impact factor: 2.129

View more
  5 in total

1.  Mode of antiviral action of silver nanoparticles against HIV-1.

Authors:  Humberto H Lara; Nilda V Ayala-Nuñez; Liliana Ixtepan-Turrent; Cristina Rodriguez-Padilla
Journal:  J Nanobiotechnology       Date:  2010-01-20       Impact factor: 10.435

2.  PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Cristina Rodriguez-Padilla
Journal:  J Nanobiotechnology       Date:  2010-07-13       Impact factor: 10.435

3.  Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatis.

Authors:  Abebayehu N Yilma; Shree R Singh; Saurabh Dixit; Vida A Dennis
Journal:  Int J Nanomedicine       Date:  2013-07-08

Review 4.  Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds.

Authors:  Humberto H Lara; Elsa N Garza-Treviño; Liliana Ixtepan-Turrent; Dinesh K Singh
Journal:  J Nanobiotechnology       Date:  2011-08-03       Impact factor: 10.435

Review 5.  Silver nanoparticles as potential antiviral agents.

Authors:  Stefania Galdiero; Annarita Falanga; Mariateresa Vitiello; Marco Cantisani; Veronica Marra; Massimiliano Galdiero
Journal:  Molecules       Date:  2011-10-24       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.